ophthalmic findings in graft versus host disease
Download
Skip this Video
Download Presentation
Ophthalmic Findings in Graft Versus Host Disease

Loading in 2 Seconds...

play fullscreen
1 / 8

Ophthalmic Findings in Graft Versus Host Disease - PowerPoint PPT Presentation


  • 232 Views
  • Uploaded on

Ophthalmic Findings in Graft Versus Host Disease. Sutton Eye Unit Epsom & St Helier University Hospitals NHS Trust Dr William R Tucker Dr Saruban Pasu Miss Andrena McElvanney. The authors have no financial interest in the subject matter or products described in this presentation. Purpose.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Ophthalmic Findings in Graft Versus Host Disease' - edward


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
ophthalmic findings in graft versus host disease

Ophthalmic Findings in Graft Versus Host Disease

Sutton Eye Unit

Epsom & St Helier University

Hospitals NHS Trust

Dr William R Tucker

Dr Saruban Pasu

Miss Andrena McElvanney

The authors have no financial interest in the subject matter or products described in this presentation

purpose
Purpose
  • To describe the clinical findings in a series of 8 patients with Graft versus Host Disease (GvHD)
  • The patients had previously received allogenic bone marrow transplant (BMT) for haematological malignancy
methods
Methods
  • All 8 patients presented to Sutton Eye Unit (UK) from the adjoining Royal Marsden Hospital
  • The Royal Marsden was the world’s first dedicated cancer hospital and is still a worldwide leader in cancer care
methods1
Methods
  • Patients presented between 2005 – 2009
  • Referred with a presumed diagnosis of ocular GvHD
  • Clinical history and examination was recorded with at least 6 months followup data collected (range 6 months to 2 years)
results demographics
Results - Demographics
  • Male:Female ratio was 1:1
  • The average age at diagnosis was 32 (range 22 – 44)
  • The underlying diseases were Acute Myeloid Leukaemia (5 patients) and Acute Lymphoblastic Leukaemia (3 patients)
  • Average time to presentation following BMT was 120 days (range 14 – 360 days)
  • 4 patients were considered to have acute GvHD having presented within 2 months
results clinical findings
Results – Clinical Findings
  • Punctate epitheliopathy present in all patients and in 4 was considered severe with development of filaments
  • Meibomian gland blockage and posterior belpharitis were present in 100% of patients
  • Average Schirmer’s test result at 5 minutes was 5mm (range 1 to 12mm)
results treatment
Results – Treatment

Disease Severity

At most recent follow-up the treatment regimen as detailed above had produced improved clinical signs and resolution of symptoms in all patients

conclusion
Conclusion
  • Ocular GvHD can adversely affect the quality of life of many patients following BMT
  • All of our cases demonstrated uncomfortable dry eyes with marked posterior blepharitis
  • Our initial treatment regimen was well tolerated
  • In our opinion specific treatment for posterior blepharitis – in this case lid hygiene and Fusidic Acid 1% gel twice a day – helped with the clinical improvement of the overall picture
ad